Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
89 hedge funds and large institutions have $400M invested in Myovant Sciences Ltd. in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 33 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 28
16% less capital invested
Capital invested by funds: $475M → $400M (-$75.2M)
19% less funds holding
Funds holding: 110 → 89 (-21)
38% less call options, than puts
Call options by funds: $5.52M | Put options by funds: $8.91M
61% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 33
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$6.23M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$5.72M |
| 3 |
Morgan Stanley
New York
|
+$1.8M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.47M |
| 5 |
Renaissance Technologies
New York
|
+$878K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$4.16M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.78M |
| 3 |
LCM
Laurion Capital Management
New York
|
-$3.11M |
| 4 |
Truist Financial
Charlotte,
North Carolina
|
-$2.62M |
| 5 |
BC
Blackcrane Capital
Bellevue,
Washington
|
-$2.17M |
MYOV Hedge Fund Activity: Q1 2022 in Review
89 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q1 2022, worth a combined $400M — down 16% from $475M a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of MYOV and 13 opened new positions — a net loss of 20 holders — while 28 trimmed existing stakes and 28 added.
The largest buyer was State Street, adding an estimated $6.23M. The largest seller was Bellevue Group, cutting an estimated $4.16M.
- 89 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q1 2022, down from 110 in Q4 2021.
- Funds reported $400M of Myovant Sciences Ltd. stock for Q1 2022, down 16% quarter-over-quarter.
- 13 funds opened new Myovant Sciences Ltd. positions in Q1 2022 and 33 closed out, a net change of -20 holders.
- The largest Myovant Sciences Ltd. buyer in Q1 2022 was State Street, an estimated $6.23M added.
- The largest Myovant Sciences Ltd. seller in Q1 2022 was Bellevue Group, an estimated $4.16M sold.
Based on aggregated 13F filings for Q1 2022.